Home › Research › Drug development
Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline
Maski K, Trotti LM, Kotagal S, Robert Auger R, Rowley JA, Hashmi SD, Watson NF.. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021-09-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
The interventions in all the recommendation statements were compared to no treatment. (STRONG). 5 We suggest that clinicians use armodafinil for the treatment of narcolepsy in adults. (CONDITIONAL). 6 We suggest that clinicians use dextroamphetamine for the treatment of narcolepsy in adults. (CONDITIONAL). 7 We suggest that clinicians use methylphenidate for the treatment of narcolepsy in adults. (STRONG). 9 We suggest that clinicians use clarithromycin for the treatment of idiopathic hypersomnia in adults. (CONDITIONAL). 10 We suggest that clinicians use methylphenidate for the treatment of idiopathic hypersomnia in adults. (CONDITIONAL). 11 We suggest that clinicians use pitolisant for the treatment of idiopathic hypersomnia in adults. (CONDITIONAL). 12 We suggest that clinicians use sodium oxybate for the treatment of idiopathic hypersomnia in adults. Adult patients with kleine-levin syndrome 13 We suggest that clinicians use lithium for the treatment of Kleine-Levin syndrome in adults. Adult patients with hypersomnia due to medical conditions Hypersomnia secondary to alpha-synucleinopathies 14 We suggest that clinicians use armodafinil for the treatment of hypersomnia secondary to dementia with Lewy bodies in adults. (CONDITIONAL). 15 We suggest that clinicians use modafinil for the treatment of hypersomnia secondary to Parkinson's disease in adults. (CONDITIONAL). 16 We suggest that clinicians use sodium oxybate for the treatment of hypersomnia secondary to Parkinson's disease in adults. Posttraumatic hypersomnia 17 We suggest that clinicians use armodafinil for the treatment of hypersomnia secondary to traumatic brain injury in adults. (CONDITIONAL). 18 We suggest that clinicians use modafinil for the treatment of hypersomnia secondary to traumatic brain injury in adults. Adult patients with genetic disorders associated with primary central nervous system somnolence 19 We suggest that clinicians use modafinil for the treatment of hypersomnia secondary to myotonic dystrophy in adults. Adult patients with hypersomnia secondary to brain tumors, infections, or other central nervous system lesions 20 We suggest that clinicians use modafinil for the treatment of hypersomnia secondary to multiple sclerosis in adults. Pediatric patients with narcolepsy 21 We suggest that clinicians use modafinil for the treatment of narcolepsy in pediatric patients. (CONDITIONAL). 22 We suggest that clinicians use sodium oxybate for the treatment of narcolepsy in pediatric p
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Maski, K., Trotti, L. M., Kotagal, S., Robert Auger, R., Rowley, J. A., Hashmi, S. D., et al. (2021). Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. https://doi.org/10.5664/jcsm.9328
Vancouver
Maski K, Trotti LM, Kotagal S, Robert Auger R, Rowley JA, Hashmi SD, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2021. doi:10.5664/jcsm.9328. PMID: 34743789.
BibTeX
@article{maski2021-34743789,
author = {Maski, K. and Trotti, L. M. and Kotagal, S. and Robert Auger, R. and Rowley, J. A. and Hashmi, S. D. and Watson, N. F.},
title = {{Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline}},
journal = {Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine},
year = {2021},
doi = {10.5664/jcsm.9328},
pmid = {34743789},
url = {https://doi.org/10.5664/jcsm.9328}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- The interventions in all the recommendation statements were compared to no treatment.
- (STRONG). 5 We suggest that clinicians use armodafinil for the treatment of narcolepsy in adults.
- (CONDITIONAL). 6 We suggest that clinicians use dextroamphetamine for the treatment of narcolepsy in adults.
- (CONDITIONAL). 7 We suggest that clinicians use methylphenidate for the treatment of narcolepsy in adults.
- (STRONG). 9 We suggest that clinicians use clarithromycin for the treatment of idiopathic hypersomnia in adults.
New to this subject? Start with our plain-English guide: Treatments →
Study details
- Study designsystematic review
- Evidence strengthHigh
How this study scored 67/100
Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for sample size, effect reported and studied in people because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 39 of the 58 points we could judge it on, which is 67 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 12 / 12 | A systematic review of all the studies on the question |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2021 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 34743789) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 39 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 39 of the 58 points we could judge it on is 67 out of 100. |
| Total | 67 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Drug development from nearby years
Also tagged “clinical-practice”
8 studies in the library carry the topic tag “clinical-practice”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 8 tagged studies.